Works by Glas, Martin


Results: 93
    1
    2
    3
    4

    Fully automated MR-based virtual biopsy of primary CNS lymphomas.

    Published in:
    Neuro-Oncology Advances, 2024, v. 6, n. 1, p. 1, doi. 10.1093/noajnl/vdae022
    By:
    • Parmar, Vicky;
    • Haubold, Johannes;
    • Salhöfer, Luca;
    • Meetschen, Mathias;
    • Wrede, Karsten;
    • Glas, Martin;
    • Guberina, Maja;
    • Blau, Tobias;
    • Bos, Denise;
    • Kureishi, Anisa;
    • Hosch, René;
    • Nensa, Felix;
    • Forsting, Michael;
    • Deuschl, Cornelius;
    • Umutlu, Lale
    Publication type:
    Article
    5
    6

    Feasibility and tolerability of trofosfamide and etoposide in progressive glioblastoma.

    Published in:
    Neuro-Oncology Advances, 2023, v. 5, n. 1, p. 1, doi. 10.1093/noajnl/vdad090
    By:
    • Schmidt, Teresa;
    • Agkatsev, Sarina;
    • Feldheim, Jonas;
    • Oster, Christoph;
    • Blau, Tobias;
    • Sure, Ulrich;
    • Keyvani, Kathy;
    • Kleinschnitz, Christoph;
    • Stuschke, Martin;
    • Herrmann, Ken;
    • Deuschl, Cornelius;
    • Scheffler, Björn;
    • Kebir, Sied;
    • Glas, Martin;
    • Lazaridis, Lazaros
    Publication type:
    Article
    7
    8
    9
    10

    Location of Recurrences after Trimodality Treatment for Glioblastoma with Respect to the Delivered Radiation Dose Distribution and Its Influence on Prognosis.

    Published in:
    Cancers, 2023, v. 15, n. 11, p. 2982, doi. 10.3390/cancers15112982
    By:
    • Guberina, Nika;
    • Padeberg, Florian;
    • Pöttgen, Christoph;
    • Guberina, Maja;
    • Lazaridis, Lazaros;
    • Jabbarli, Ramazan;
    • Deuschl, Cornelius;
    • Herrmann, Ken;
    • Blau, Tobias;
    • Wrede, Karsten H.;
    • Keyvani, Kathy;
    • Scheffler, Björn;
    • Hense, Jörg;
    • Layer, Julian P.;
    • Glas, Martin;
    • Sure, Ulrich;
    • Stuschke, Martin
    Publication type:
    Article
    11

    BRMS1 in Gliomas—An Expression Analysis.

    Published in:
    Cancers, 2023, v. 15, n. 11, p. 2907, doi. 10.3390/cancers15112907
    By:
    • Feldheim, Jonas;
    • Kessler, Almuth F.;
    • Feldheim, Julia J.;
    • Schmitt, Dominik;
    • Oster, Christoph;
    • Lazaridis, Lazaros;
    • Glas, Martin;
    • Ernestus, Ralf-Ingo;
    • Monoranu, Camelia M.;
    • Löhr, Mario;
    • Hagemann, Carsten
    Publication type:
    Article
    12

    Fully Automated MR Based Virtual Biopsy of Cerebral Gliomas.

    Published in:
    Cancers, 2021, v. 13, n. 24, p. 6186, doi. 10.3390/cancers13246186
    By:
    • Haubold, Johannes;
    • Hosch, René;
    • Parmar, Vicky;
    • Glas, Martin;
    • Guberina, Nika;
    • Catalano, Onofrio Antonio;
    • Pierscianek, Daniela;
    • Wrede, Karsten;
    • Deuschl, Cornelius;
    • Forsting, Michael;
    • Nensa, Felix;
    • Flaschel, Nils;
    • Umutlu, Lale
    Publication type:
    Article
    13
    14
    15
    16

    Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy—the MecMeth/NOA-24 trial.

    Published in:
    Trials, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s13063-021-05977-0
    By:
    • Zeyen, Thomas;
    • Potthoff, Anna-Laura;
    • Nemeth, Robert;
    • Heiland, Dieter H.;
    • Burger, Michael C.;
    • Steinbach, Joachim P.;
    • Hau, Peter;
    • Tabatabai, Ghazaleh;
    • Glas, Martin;
    • Schlegel, Uwe;
    • Grauer, Oliver;
    • Krex, Dietmar;
    • Schnell, Oliver;
    • Goldbrunner, Roland;
    • Sabel, Michael;
    • Thon, Niklas;
    • Delev, Daniel;
    • Clusmann, Hans;
    • Seidel, Clemens;
    • Güresir, Erdem
    Publication type:
    Article
    17

    Prognostic factors in recurrent glioblastoma patients treated with bevacizumab.

    Published in:
    Journal of Neuro-Oncology, 2016, v. 129, n. 1, p. 93, doi. 10.1007/s11060-016-2144-7
    By:
    • Schaub, Christina;
    • Tichy, Julia;
    • Schäfer, Niklas;
    • Franz, Kea;
    • Mack, Frederic;
    • Mittelbronn, Michel;
    • Kebir, Sied;
    • Thiepold, Anna-Luisa;
    • Waha, Andreas;
    • Filmann, Natalie;
    • Banat, Mohammed;
    • Fimmers, Rolf;
    • Steinbach, Joachim;
    • Herrlinger, Ulrich;
    • Rieger, Johannes;
    • Glas, Martin;
    • Bähr, Oliver
    Publication type:
    Article
    18
    19
    20

    INTERCEPT H3: a multicenter phase I peptide vaccine trial for the treatment of H3-mutated diffuse midline gliomas.

    Published in:
    Neurological Research & Practice, 2023, v. 5, n. 1, p. 1, doi. 10.1186/s42466-023-00282-4
    By:
    • Grassl, Niklas;
    • Sahm, Katharina;
    • Süße, Heike;
    • Poschke, Isabel;
    • Bunse, Lukas;
    • Bunse, Theresa;
    • Boschert, Tamara;
    • Mildenberger, Iris;
    • Rupp, Anne-Kathleen;
    • Ewinger, Max Philipp;
    • Lanz, Lisa-Marie;
    • Denk, Monika;
    • Tabatabai, Ghazaleh;
    • Ronellenfitsch, Michael W.;
    • Herrlinger, Ulrich;
    • Glas, Martin;
    • Krex, Dietmar;
    • Vajkoczy, Peter;
    • Wick, Antje;
    • Harting, Inga
    Publication type:
    Article
    21

    AMPLIFY-NEOVAC: a randomized, 3-arm multicenter phase I trial to assess safety, tolerability and immunogenicity of IDH1-vac combined with an immune checkpoint inhibitor targeting programmed death-ligand 1 in isocitrate dehydrogenase 1 mutant gliomas.

    Published in:
    Neurological Research & Practice, 2022, v. 4, n. 1, p. 1, doi. 10.1186/s42466-022-00184-x
    By:
    • Bunse, Lukas;
    • Rupp, Anne-Kathleen;
    • Poschke, Isabel;
    • Bunse, Theresa;
    • Lindner, Katharina;
    • Wick, Antje;
    • Blobner, Jens;
    • Misch, Martin;
    • Tabatabai, Ghazaleh;
    • Glas, Martin;
    • Schnell, Oliver;
    • Gempt, Jens;
    • Denk, Monika;
    • Reifenberger, Guido;
    • Bendszus, Martin;
    • Wuchter, Patrick;
    • Steinbach, Joachim P;
    • Wick, Wolfgang;
    • Platten, Michael
    Publication type:
    Article
    22
    23

    Individual glioblastoma cells harbor both proliferative and invasive capabilities during tumor progression.

    Published in:
    Neuro-Oncology, 2023, v. 25, n. 12, p. 2150, doi. 10.1093/neuonc/noad109
    By:
    • Ratliff, Miriam;
    • Karimian-Jazi, Kianush;
    • Hoffmann, Dirk C;
    • Rauschenbach, Laurèl;
    • Simon, Matthias;
    • Hai, Ling;
    • Mandelbaum, Henriette;
    • Schubert, Marc C;
    • Kessler, Tobias;
    • Uhlig, Stefanie;
    • Azorin, Daniel Dominguez;
    • Jung, Erik;
    • Osswald, Matthias;
    • Solecki, Gergely;
    • Maros, Máté E;
    • Venkataramani, Varun;
    • Glas, Martin;
    • Etminan, Nima;
    • Scheffler, Björn;
    • Wick, Wolfgang
    Publication type:
    Article
    24

    Endothelial cell-derived angiopoietin-2 is a therapeutic target in treatment-naive and bevacizumab-resistant glioblastoma.

    Published in:
    EMBO Molecular Medicine, 2016, v. 8, n. 1, p. 39, doi. 10.15252/emmm.201505505
    By:
    • Scholz, Alexander;
    • Harter, Patrick N;
    • Cremer, Sebastian;
    • Yalcin, Burak H;
    • Gurnik, Stefanie;
    • Yamaji, Maiko;
    • Di Tacchio, Mariangela;
    • Sommer, Kathleen;
    • Baumgarten, Peter;
    • Bähr, Oliver;
    • Steinbach, Joachim P;
    • Trojan, Jörg;
    • Glas, Martin;
    • Herrlinger, Ulrich;
    • Krex, Dietmar;
    • Meinhardt, Matthias;
    • Weyerbrock, Astrid;
    • Timmer, Marco;
    • Goldbrunner, Roland;
    • Deckert, Martina
    Publication type:
    Article
    25
    26
    27

    NOA-05 phase 2 trial of procarbazine and lomustine therapy in gliomatosis cerebri.

    Published in:
    Annals of Neurology, 2011, v. 70, n. 3, p. 445, doi. 10.1002/ana.22478
    By:
    • Glas, Martin;
    • Bähr, Oliver;
    • Felsberg, Jörg;
    • Rasch, Katja;
    • Wiewrodt, Dorothee;
    • Schabet, Martin;
    • Simon, Matthias;
    • Urbach, Horst;
    • Steinbach, Joachim P.;
    • Rieger, Johannes;
    • Fimmers, Rolf;
    • Bamberg, Michael;
    • Nägele, Thomas;
    • Reifenberger, Guido;
    • Weller, Michael;
    • Herrlinger MD, Ulrich;
    • Group of the German Cancer Society, for the Neuro-Oncology
    Publication type:
    Article
    28

    Residual tumor cells are unique cellular targets in glioblastoma.

    Published in:
    Annals of Neurology, 2010, v. 68, n. 2, p. 264, doi. 10.1002/ana.22036
    By:
    • Glas, Martin;
    • Rath, Barbara H.;
    • Simon, Matthias;
    • Reinartz, Roman;
    • Schramme, Anja;
    • Trageser, Daniel;
    • Eisenreich, Ramona;
    • Leinhaas, Anke;
    • Keller, Mihaela;
    • Schildhaus, Hans-Ulrich;
    • Garbe, Stephan;
    • Steinfarz, Barbara;
    • Pietsch, Torsten;
    • Steindler, Dennis A.;
    • Schramm, Johannes;
    • Herrlinger, Ulrich;
    • Brüstle, Oliver;
    • Scheffler, Björn
    Publication type:
    Article
    29
    30
    31

    L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy in newly-diagnosed glioblastoma: dose escalation of the phase I/II GLORIA trial.

    Published in:
    Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-48416-9
    By:
    • Giordano, Frank A.;
    • Layer, Julian P.;
    • Leonardelli, Sonia;
    • Friker, Lea L.;
    • Turiello, Roberta;
    • Corvino, Dillon;
    • Zeyen, Thomas;
    • Schaub, Christina;
    • Müller, Wolf;
    • Sperk, Elena;
    • Schmeel, Leonard Christopher;
    • Sahm, Katharina;
    • Oster, Christoph;
    • Kebir, Sied;
    • Hambsch, Peter;
    • Pietsch, Torsten;
    • Bisdas, Sotirios;
    • Platten, Michael;
    • Glas, Martin;
    • Seidel, Clemens
    Publication type:
    Article
    32
    33
    34

    Primary CNS lymphoma: a clinician's guide.

    Published in:
    Expert Review of Neurotherapeutics, 2012, v. 12, n. 10, p. 1197, doi. 10.1586/ERN.12.120
    By:
    • Schäfer, Niklas;
    • Glas, Martin;
    • Herrlinger, Ulrich
    Publication type:
    Article
    35
    36
    37
    38
    39
    40
    41
    42
    43

    A novel serum extracellular vesicle protein signature to monitor glioblastoma tumor progression.

    Published in:
    International Journal of Cancer, 2023, v. 152, n. 2, p. 308, doi. 10.1002/ijc.34261
    By:
    • Tzaridis, Theophilos;
    • Weller, Johannes;
    • Bachurski, Daniel;
    • Shakeri, Farhad;
    • Schaub, Christina;
    • Hau, Peter;
    • Buness, Andreas;
    • Schlegel, Uwe;
    • Steinbach, Joachim‐Peter;
    • Seidel, Clemens;
    • Goldbrunner, Roland;
    • Schäfer, Niklas;
    • Wechsler‐Reya, Robert J.;
    • Hallek, Michael;
    • Scheffler, Björn;
    • Glas, Martin;
    • Haeberle, Lothar;
    • Herrlinger, Ulrich;
    • Coch, Christoph;
    • Reiners, Katrin S.
    Publication type:
    Article
    44

    MGMT promoter methylation analysis for allocating combined CCNU/TMZ chemotherapy: Lessons learned from the CeTeG/NOA‐09 trial.

    Published in:
    International Journal of Cancer, 2021, v. 148, n. 7, p. 1695, doi. 10.1002/ijc.33363
    By:
    • Tzaridis, Theophilos;
    • Schäfer, Niklas;
    • Weller, Johannes;
    • Steinbach, Joachim‐Peter;
    • Schlegel, Uwe;
    • Seidel, Sabine;
    • Sabel, Michael;
    • Hau, Peter;
    • Seidel, Clemens;
    • Krex, Dietmar;
    • Goldbrunner, Roland;
    • Tonn, Jörg‐Christian;
    • Grauer, Oliver;
    • Kebir, Sied;
    • Schneider, Matthias;
    • Schaub, Christina;
    • Vatter, Hartmut;
    • Coch, Christoph;
    • Glas, Martin;
    • Fimmers, Rolf
    Publication type:
    Article
    45
    46
    47
    48
    49
    50